Abbott to Buy Cancer-Screener Exact Sciences for $21 Billion
PositiveFinancial Markets

- Abbott Laboratories has announced its acquisition of Exact Sciences Corp. for $21 billion, enhancing its position in the cancer screening market.
- This strategic move is expected to bolster Abbott's capabilities in healthcare, particularly in cancer diagnostics, aligning with its growth objectives.
- The acquisition highlights a trend of consolidation in the healthcare sector, as companies seek to expand their portfolios and innovate in cancer detection technologies.
— via World Pulse Now AI Editorial System







